Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 11/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.36 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1117439 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1170874 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1171207 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1117334 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1170931 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1117393 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1170888 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1117483 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1170680 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 | |
| SCHEMBL1170909 | 0.98 | ALDH1A1 (0.43) | ALDH1A1FDPSGGPS1CES2LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542277-B2 | Nitrated hydrocarbons, derivatives, and processes for their manufacture | ANGUS CHEMICAL COMPANY (US) | 2023-01-03 | — | — | US | disclosed |
| US-20190315768-A1 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE | ADVANCION CORPORATION | 2019-10-17 | — | — | US | disclosed |
| US-10377771-B2 | Nitrated hydrocarbons, derivatives, and processes for their manufacture | ANGUS CHEMICAL COMPANY (US) | 2019-08-13 | — | — | US | disclosed |
| US-20180127435-A1 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE | ADVANCION CORPORATION | 2018-05-10 | — | — | US | disclosed |
| US-9890177-B2 | Nitrated hydrocarbons, derivatives, and processes for their manufacture | ANGUS CHEMICAL COMPANY (US) | 2018-02-13 | — | — | US | disclosed |
| US-20160039843-A1 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE | ADVANCION CORPORATION | 2016-02-11 | — | — | US | disclosed |
| US-9187436-B2 | Nitrated hydrocarbons, derivatives, and processes for their manufacture | ANGUS CHEMICAL COMPANY (US) | 2015-11-17 | — | — | US | disclosed |
| US-20110028732-A1 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE | ANGUS CHEMICAL COMPANY (US) | 2011-02-03 | — | — | US | disclosed |
| US-5500484-A | FROM ALDEHYDE | KURARAY CO., LTD. (JP) | 1996-03-19 | — | — | US | disclosed |
| EP-0641757-A1 | 2-Aryl-1,3-propanediol and dioxane derivatives and their preparation | KURARAY CO., LTD. (JP) | 1995-03-08 | — | — | EP | disclosed |
| US-4999369-A | Antitumor agents | BURROUGHS WELLCOME CO. (US) | 1991-03-12 | — | — | US | disclosed |
| US-4910218-A | With a hydroxy containing secondary amine group | BURROUGHS WELLCOME CO. (US) | 1990-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127435-A1 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE | NOS2, NOS1, NOS3 | ALDH1A1 1410/4885LMNA 1670/4885FDPS 265/4885 |
| US-11542277-B2 | Nitrated hydrocarbons, derivatives, and processes for their manufacture | NOS2, NOS1, NOS3 | ALDH1A1 1410/4885LMNA 1670/4885FDPS 265/4885 |
| US-20190315768-A1 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE | NOS2, NOS1, NOS3 | ALDH1A1 1410/4885LMNA 1670/4885FDPS 265/4885 |
| US-20110028732-A1 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE | NOS2, NOS1, NOS3 | ALDH1A1 1410/4885LMNA 1670/4885FDPS 265/4885 |
| US-20160039843-A1 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE | NOS2, NOS1, NOS3 | ALDH1A1 1410/4885LMNA 1670/4885FDPS 265/4885 |
| US-10377771-B2 | Nitrated hydrocarbons, derivatives, and processes for their manufacture | NOS2, NOS1, NOS3 | ALDH1A1 1410/4885LMNA 1670/4885FDPS 265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.